Follow us on
 
Learn To Trade Market Profile Arbitrage — Proven Strategy

Tuesday, April 02, 2019 4:30PM EDT
Presenter: Sean Kozak — NEUROSTREET

✨†This, Tuesday, April 2ndat 4:30PM ET- we are proud to†feature❝Learn To Trade Market Profile Arbitrage — Proven Strategy❞†presented by Sean Kozak of NeuroStreet.com


 Watch this video of NEUROSTREET Trading the ❝FOMC Report❞ Recently Below:



TO REGISTER NOW,††Click Here


Sean Kozak is a global assets trader specializing in technical strategies for day & swing trading. His passion for trading influenced him to develop comprehensive software products & training programs designed to teach others.†


Sean is the President of NEUROSTREET whose chief aim is to provide:

𝕊 Cutting Edge Neuroscience for Cognitive Trader Training.

𝕊 Top-Tier Trading Software.

𝕊 Experienced Trading Educators With Proven Track Records.

𝕊 Multiple Trading Rooms in cooperation with Master Education Programs.

𝕊 Multiple Platform Integration For Diversified Traders.



Sign up for a free guest pass for our trade room ~ HERE ~†

We look forward to having you all in our live webcast Tuesday, April 2nd, at 4:30PM Eastern Time, so sign up NOW, so you don't chance missing this event!


Sean Kozak †- President

For pre-session questions email the staff at NEUROSTREET to:†support@neurostreet.com


✨† More Information about NEUROSTREET on the WWW:

VISIT our website: www.NeuroStreet.com

✉†EMAIL us to: Support@neurostreet.com

☎†CALL us to: +1—(708) TRADE—NS

FOLLOW us on TWITTER: @NeuroStreet

LIKE us on: Facebook

SUBSCRIBE to our CHANNEL on: YouTube

CONNECT with us on: LinkedIn



Disclaimer:† Stocks, Options,†Futures and Forex trading contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing onesí financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. For our full risk disclaimer, review the terms on our website.